These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4994808)
61. Subacute myelo-opticoneuropathy following pneumonitis. Wolfe MS Am J Clin Pathol; 1977 Jul; 68(1):95-6. PubMed ID: 405861 [No Abstract] [Full Text] [Related]
62. [Report on subacute-myelo-optico-neuropathy (SMON) by the Joint Study Unit. 2]. Iryo; 1971 Dec; 25(12):921-51. PubMed ID: 5147605 [No Abstract] [Full Text] [Related]
63. A nephropathy in the genesis of S.M.O.N.? de Crousaz G; Voumard C; de Werra P Lancet; 1973 Feb; 1(7799):378. PubMed ID: 4121977 [No Abstract] [Full Text] [Related]
64. [Subacute myelopathy during a course of treatment with clioquinol in a patient colectomized for Crohn's disease]. Fabiani F; Pompili A; Scarinci A; Sinibaldi L Riv Neurobiol; 1978; 24(1-2):121-37. PubMed ID: 161413 [No Abstract] [Full Text] [Related]
65. [Activated T cells in the peripheral blood of patients with subacute myelo-optico-neuropathy (SMON)]. Matsuda M; Miyagi K; Yanagisawa N; Tsukada N Arerugi; 1994 Mar; 43(3):515-20. PubMed ID: 8198461 [TBL] [Abstract][Full Text] [Related]
66. Electron microscopic demonstration of a new virus isolated from a patient with SMON. Ota Z Acta Med Okayama (1952); 1970; 24(6):573-7. PubMed ID: 4258715 [No Abstract] [Full Text] [Related]
67. Subacute myelo-optic neuropathy. A toxic or a viral etiology? Otte G; De Coster W; Thiery E; De Reuck J; Vander eecken H Acta Neurol Belg; 1976; 76(5-6):331-4. PubMed ID: 137650 [TBL] [Abstract][Full Text] [Related]
68. [Peripheral nerve diseases in SMON. 3. Comparison of teased nerve fibers taken from patients with SMON and from normal controls]. Tsukagoshi H; Togi H Rinsho Shinkeigaku; 1972 Aug; 12(8):372-80. PubMed ID: 4674288 [No Abstract] [Full Text] [Related]
69. Antibody response in cases of S.M.O.N. against the associated virus. Inoue YK; Nishibe Y; Kimura T; Shimada Y; Yamada G Lancet; 1972 Sep; 2(7779):705-6. PubMed ID: 4115835 [No Abstract] [Full Text] [Related]
75. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Topaloglu H; Berker M; Kansu T; Saatci U; Renda Y Lancet; 1992 Jan; 339(8786):178-9. PubMed ID: 1346027 [No Abstract] [Full Text] [Related]
76. Letter: SMON probably occurred in 1938 in Japan. Katahira K JAMA; 1976 Aug; 236(8):919. PubMed ID: 781337 [No Abstract] [Full Text] [Related]
77. [Effect of sex hormones in the therapy of SMON]. Shibata T; Osawa H Horumon To Rinsho; 1970 Jan; 18(1):67-9. PubMed ID: 5461281 [No Abstract] [Full Text] [Related]